Makina vs Mitosis: managed yield or cross-chain liquidity? (2026)

Makina and Mitosis address different problems despite sharing the onchain capital allocator label. Makina provides vault infrastructure called Machines: Operators package strategies that allocate capital across protocols and chains, while depositors retain custody of their assets. Its strategy mandates and risk parameters are described as enforced onchain. Mitosis is an L1 that turns liquidity positions into programmable assets. Users deposit into its treasury and receive tokens representing those deposits, which can be used across chains without separately bridging for each application.

The distinction is practical. Choose Makina if you want an Operator-managed yield strategy and are prepared to assess its manager and strategy risks. Choose Mitosis if you care more about making liquidity positions transferable and reusable across applications. Mitosis also offers targeted liquidity campaigns and composable infrastructure for applications, whereas Makina’s main user-facing product is its collection of yield Machines.

Mitosis lists twelve chains, compared with Makina’s two: Ethereum and Base. That gives Mitosis broader listed chain coverage, and its design aims to reduce the need for separate bridging when users access applications. Makina also describes cross-chain deployment, but the listed networks are limited to Ethereum and Base. Its Machines include USD, ETH, BTC and tokenized-stock strategies; some are private or gated.

Neither project publishes a fee schedule here, so compare costs in the relevant app and official documentation before depositing. Makina’s Machine pages may show APYs, including 30-day or target figures, but these are not guaranteed. Mitosis does not state yield figures here. Normal network gas applies to deposits and withdrawals on the networks involved; Mitosis users may also encounter costs when depositing, withdrawing or trading tokenized positions. The projects do not provide enough published fee detail to say which is cheaper.

Both projects list two audits, but the auditors and audit reports are not named in the details here. An audit count alone does not establish that contracts are safe, so check the official documentation for report scope and dates before committing funds. Neither project’s fee information resolves the separate question of contract risk.

Makina users take on smart-contract risk as well as risks from Operators, the protocols used by a Machine and cross-chain execution. The homepage mentions optional coverage powered by Nexus Mutual, but its terms are not given publicly. Mitosis’s cross-chain model involves smart contracts, messaging and settlement layers that can fail; its homepage says applications cannot access user funds and can only route through Mitosis. Treat that as a project claim, not independent verification. Mitosis lists a status page, but a status page does not remove protocol risk. Keep position sizes appropriate to the risks you understand.

Makina has the higher listed TVL at about $39 million, compared with Mitosis at about $1.3 million. These figures are not a guarantee of safety or future adoption, but they do show a substantial difference in current listed scale. Makina’s product is more directly aimed at depositors choosing managed strategies. Named Operators offer Machines across several asset categories, and the homepage also shows tokenized-stock yield products on Base.

Mitosis’s central proposition is infrastructure: tokenized LP positions, cross-chain settlement and tools for applications that want to route liquidity. It lists more chains and has a MITO token, but its stated value depends on the Mitosis chain and token economics gaining adoption among DeFi projects. Its TVL is relatively small. If you are primarily looking for an existing managed-yield product, Makina is the clearer match. If you want to explore programmable liquidity and accept adoption risk, Mitosis is the more relevant option.

Pick Makina if you want to deposit into managed yield strategies and are willing to evaluate Operators, Machine mandates, underlying protocols and any applicable coverage terms. Its non-custodial design and curated Machines give it a more direct depositor focus. Check each Machine’s live terms: fees are not published in a general schedule, and displayed APYs are not guaranteed. Makina’s listed coverage of Ethereum and Base may also be limiting if you need other chains.

Pick Mitosis if your priority is making liquidity positions portable and usable across a wider set of chains, or if you are evaluating infrastructure for an application. Its twelve-chain list and tokenized LP model are its main distinctions. Balance those features against its smaller listed TVL, unpublished fees and yields, and the adoption needs of its own chain. Neither is an obvious choice for someone who requires a fully published fee schedule or named audit reports before using a protocol.